Company Name: Dermira, Inc.
Dermira, Inc. is a biopharmaceutical company. The company is engaged in the development and commercialization of therapies for dermatologic diseases. The company’s pipeline includes product candidates designed to treat:
- Moderate-to-severe chronic plaque psoriasis
Ticker Symbol: DERM (NASDAQ)
Company Website: http://dermira.com
Social Media: Dermira LinkedIn
Headquarters: Menlo Park, CA